R. Nelson

Endocrinology, Diabetes and Metabolism · 2012

A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom R. Nelson trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. P. P. Toth

Papers from R. Nelson's perspective

Ordered by how strongly the researchers R. Nelson trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis. (Journal of the American Medical Association (JAMA))
  2. Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy. (Journal of the American College of Cardiology)
  3. Lipoprotein(a) as a cardiovascular risk factor: current status (European Heart Journal)
  4. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. (New England Journal of Medicine)
  5. Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
  6. Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus (New England Journal of Medicine)
  7. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. (Journal of the American Medical Association (JAMA))
  8. Comparison of Novel Risk Markers for Improvement in Cardiovascular Risk Assessment in Intermediate Risk Individuals. The Multi-Ethnic Study of Atherosclerosis (Journal of the American Medical Association (JAMA))
  9. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. (The Lancet)
  10. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study (The Lancet)

Their papers